Cargando…

Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome

Recent insight into the underlying molecular and cellular mechanisms of fragile X syndrome (FXS) has led to the proposal and development of new pharmaceutical treatment strategies, and the initiation of clinical trials aimed at correcting core symptoms of the developmental disorder. Consequently, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farzin, Faraz, Scaggs, Felicia, Hervey, Crystal, Berry-Kravis, Elizabeth, Hessl, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2011
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196645/ https://www.ncbi.nlm.nih.gov/pubmed/21267642 http://dx.doi.org/10.1007/s10803-011-1176-2

Ejemplares similares

Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
por: Knox, Andrew, et al.
Publicado: (2012)

Targeted treatments for fragile X syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2011)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2012)

Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome
por: Hessl, David, et al.
Publicado: (2019)

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
por: Berry-Kravis, E, et al.
Publicado: (2009)

Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives
por: Lozano, Reymundo, et al.
Publicado: (2022)

Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities
por: Weber, Jayne Dixon, et al.
Publicado: (2019)

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
por: Budimirovic, Dejan B., et al.
Publicado: (2017)

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
por: Luu, Skylar, et al.
Publicado: (2020)

Best Practices in Fragile X Syndrome Treatment Development
por: Erickson, Craig A., et al.
Publicado: (2018)

Investigating the Reliability of Pupillometry as a Measure of Individualized Listening Effort
por: Neagu, Mihaela-Beatrice, et al.
Publicado: (2023)

Others’ emotions teach, but not in autism: an eye-tracking pupillometry study
por: Nuske, Heather J., et al.
Publicado: (2016)

Dynamic Object Representations in Infants with and without Fragile X Syndrome
por: Farzin, Faraz, et al.
Publicado: (2010)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome
por: Coffman, Marika C., et al.
Publicado: (2020)

Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A
por: Alusi, Ghassan, et al.
Publicado: (2022)

A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome
por: Lee, Michelle, et al.
Publicado: (2016)

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
por: Lee, Anna W., et al.
Publicado: (2018)

Erratum to: A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome
por: Lee, Michelle, et al.
Publicado: (2017)

X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
por: Hall, Deborah A., et al.
Publicado: (2016)

Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome
por: Reisinger, Debra L., et al.
Publicado: (2020)

The challenges of clinical trials in fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2013)

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice
por: Westmark, Cara J., et al.
Publicado: (2011)

New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
por: Fraint, Avram, et al.
Publicado: (2014)

Pupillometry Tracks Errors in Interval Timing
por: Warda, Shamini, et al.
Publicado: (2022)

Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome
por: Westmark, Cara J., et al.
Publicado: (2020)

Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010)

Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment
por: Hoffmann, Anne, et al.
Publicado: (2020)

Vocabulary comprehension in adults with fragile X syndrome (FXS)
por: Hoffmann, Anne, et al.
Publicado: (2019)

Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization
por: Cordeiro, Lisa, et al.
Publicado: (2010)

Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity
por: Abbeduto, Leonard, et al.
Publicado: (2020)

The confounding effects of eye blinking on pupillometry, and their remedy
por: Yoo, Kyung, et al.
Publicado: (2021)

Reactivity to fearful expressions of familiar and unfamiliar people in children with autism: an eye-tracking pupillometry study
por: Nuske, Heather J, et al.
Publicado: (2014)

Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity
por: Abbeduto, Leonard, et al.
Publicado: (2020)

Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human Cells
por: Zhang, Jiang, et al.
Publicado: (2019)

Executive Function in Fragile X Syndrome: A Systematic Review
por: Schmitt, Lauren M., et al.
Publicado: (2019)

Arbaclofen in fragile X syndrome: results of phase 3 trials
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2017)

Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome
por: Kerr, Cicely, et al.
Publicado: (2014)

ASFMR1 splice variant: A predictor of fragile X-associated tremor/ataxia syndrome
por: Vittal, Padmaja, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d159ri2ps6de7ev7mse2m66sji